copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Marya Ghazipura Defends Dissertation | Marron Institute Dr Marya Ghazipura, graduate assistant in the Health, Environment, and Policy program, successfully defended her doctoral dissertation, “Effects of Air Pollution on Interstitial Lung Diseases,” at the end of May
Nintedanib in Progressive Pulmonary Fibrosis: A Systematic . . . - PubMed Conclusions: Nintedanib use in patients with PPF is associated with a statistically significant decrease in disease progression but increase in gastrointestinal side effects regardless of the radiographic pattern of pulmonary fibrosis
American Journal of Respiratory and Critical Care Medicine Conclusions: These guidelines provide the basis for evidence-based use of home oxygen therapy in adults with COPD or ILD but also highlight the need for additional research to guide clinical practice Keywords: mobility; hypoxemia; quality of life; chronic obstructive pulmonary disease; interstitial lung disease
(PDF) Cardiopulmonary Risk of Waterpipe Smoke: A Meta-Analysis | Marya . . . Marshall MR, Ghazipura M, Hossain T, Gordon T, Chen LC J Lung Health Dis (2018) 2 (1): 31-40 Research Article Open Access Cardiopulmonary Risk of Waterpipe Smoke: A Meta-Analysis Matthew Randolph Marshall1*, Marya Ghazipura2, Tanzib Hossain3, Terry Gordon1, Lung-Chi Chen1 1 New York University School of Medicine, Department of Environmental Health Sciences, New York University Langone Medical
High NO2 concentration in winter: a risk factor for ILD patients “The body of evidence on the effect of air pollution on pulmonary disease is quite large, but if it comes to interstitial lung disease (ILD), knowledge on air pollution is still in its infancy,” Dr Marya Ghazipura (Marron Institute of Urban Management, NY, USA) said [1]
| Marron Institute The Director’s Office, led by the Director of NYU Marron Institute, opportunely engages with researchers on urban-focused projects that can develop into full programs if they demonstrate impact and are viable
Nintedanib Therapy Alone and Combined with Mycophenolate in Patients . . . Conclusions: The use of nintedanib alone and in combination with mycophenolate in patients with SSc-ILD is associated with a significant reduction in disease progression compared with placebo but at the cost of increased gastrointestinal side effects and treatment discontinuation The quality of evidence is very low